What is Borqs Technologi's earnings per share (EPS)?

Borqs Technologi (BRQSF) reported diluted earnings per share of $0.16 for fiscal year 2025. This represents a -70.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Borqs Technologi (BRQSF) Financials

BRQSF

FY2025 annual

Revenue $13.6M -50.9% YoY

Net Income $5.4M -67.9% YoY

EPS (Diluted) $0.16 -70.9% YoY

Free Cash Flow -$27.9M -869.0% YoY

Market Cap $4.9M as of Sep 3, 2026

Price / Sales 0.4x on $13.6M revenue, FY2025

Price / Earnings 0.9x on $5.4M net income, FY2025

Price / Book 0.7x on $6.7M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported May 15, 2026 Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed May 15, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BRQSF SEC filings page.

Borqs Technologi (BRQSF) reported $13.6M in revenue for fiscal year 2025, down 50.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BRQSF FY2025 2026-08-30

The dominant mechanic is a shrinking operating business whose reported profit is increasingly separated from cash generation and core operations.

FY2025’s positive net income of $5.4M coexisted with operating income of -$17.4M, so reported profit did not come from the core operating engine. Operating cash flow and free cash flow were both approximately -$27.9M, making cash conversion the central issue because earnings and cash tell materially different stories.

Revenue fell to $13.6M while gross margin compression reduced margin to 3.7% in FY2025; the business lost economic room before overhead. SG&A still reached $14.2M, creating an overhead burden larger than gross profit and helping explain the operating loss.

Equity moved from -$3.4M in FY2024 to $6.7M in FY2025, while the current ratio rose to 5.4x, indicating a balance-sheet reset. The concurrent investing cash inflow of $25.1M alongside operating cash outflow suggests asset monetization or other non-operating funding, rather than internally generated cash supporting the improvement.

Financial Health Signals

Financial health score not available

Borqs Technologi does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-52.95

Borqs Technologi scores -52.95, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.9M) relative to total liabilities ($1.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

Borqs Technologi passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

$5.20used

For every $1 of reported earnings, Borqs Technologi used $5.20 of operating cash (-$27.9M OCF vs $5.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$2.6M

YoY+28.7%

QoQ-72.7%

5Y CAGR-3.9%

Borqs Technologi held $2.6M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding

45M

YoY+57.0%

Borqs Technologi had 45M shares outstanding in Q4 2025. This represents an increase of 57.0% from the same quarter a year earlier.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

BRQSF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRQSF quarterly income statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$13.6M-50.9%	$27.7M+34.7%	$20.6M-50.1%	$41.2M+39.4%	$29.6M+10.5%	$26.8M-73.0%	$99.0M-22.9%	$128.4M+5.1%	$122.2M+43.0%	$85.4M+13.8%	$75.1M
Cost of Revenue	$13.1M-40.2%	$21.9M+31.3%	$16.7M+171.5%	$6.1M-34.8%	$9.4M-2.7%	$9.7M-45.6%	$17.8M+104.4%	$8.7M+20.3%	$7.2M-3.3%	$7.5M-87.1%	$58.0M
Gross Profit	$500K-91.4%	$5.8M+49.5%	$3.9M-30.1%	$5.5M+112.5%	$2.6M+63.3%	$1.6M+180.5%	$569K-99.5%	$119.7M+538.8%	$18.7M-8.6%	$20.5M+20.1%	$17.1M
R&D Expenses	$3.5M+51.9%	$2.3M-36.6%	$3.7M+8.1%	$3.4M-36.1%	$5.3M-35.1%	$8.2M+54.6%	$5.3M-16.7%	$6.3M+2.3%	$6.2M+14.8%	$5.4M-25.1%	$7.2M
SG&A Expenses	$14.2M+119.1%	$6.5M-41.7%	$11.1M+103.8%	$5.4M-76.9%	$23.6M+22996.1%	$102K-99.6%	$24.8M-52.4%	$52.0M+179.5%	$18.6M+162.9%	$7.1M+45.0%	$4.9M
Operating Income	-$17.4M-454.3%	-$3.1M+72.3%	-$11.3M-228.9%	-$3.4M+86.8%	-$26.1M+35.6%	-$40.6M-39.3%	-$29.2M+56.3%	-$66.7M-693.0%	-$8.4M-196.6%	$8.7M+1120.9%	$713K
EBITDA	-$17.4M-535.3%	-$2.7M+75.0%	-$10.9M-255.4%	-$3.1M+88.2%	-$26.0M+35.7%	-$40.5M-39.3%	-$29.1M+56.1%	-$66.3M-1677.7%	-$3.7M-131.4%	$11.9M+271.5%	$3.2M
Interest Expense	N/A	$770K+10.0%	$700K-94.0%	$11.7M+0.4%	$11.7M+207.8%	$3.8M-23.7%	$5.0M+92.9%	$2.6M+40.7%	$1.8M+115.0%	$852K+446.2%	$156K
Income Tax	$5K-37.5%	$8K+100.4%	-$2.1M-208500.0%	$1K+100.2%	-$445K-209.6%	$406K+142.8%	-$949K-386.7%	$331K-85.9%	$2.3M-27.8%	$3.2M+281.2%	$851K
Net Income	$5.4M-67.9%	$16.7M+163.1%	-$26.5M+22.2%	-$34.0M+39.1%	-$55.9M-60.6%	-$34.8M+2.7%	-$35.7M+50.2%	-$71.8M-471.0%	-$12.6M-489.4%	$3.2M+52.9%	$2.1M
EPS (Basic)	$0.16-70.9%	$0.55+127.1%	-$2.03+88.6%	-$17.79+80.4%	-$90.95-612.8%	-$12.76-1229.2%	-$0.96+58.3%	-$2.30-51.3%	-$1.52	$0.00+100.0%	-$0.07
EPS (Diluted)	$0.16-70.9%	$0.55	-$2.03	-$17.79	-$90.95	-$12.76	-$0.96+58.3%	-$2.30	-$1.52	$0.00+100.0%	-$0.07
Diluted Shares (Avg)	33M+8.2%	30M	13M	2M	614,227	3M	36M+15.1%	31M	13M	6M+31.6%	4M

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

BRQSF Balance Sheet

BRQSF quarterly balance sheet

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$8.6M-66.3%	$25.4M+18.6%	$21.4M-28.9%	$30.1M-43.4%	$53.3M+81.4%	$29.4M-48.3%	$56.8M-29.3%	$80.4M-50.7%	$163.0M+108.9%	$78.0M+28.9%	$60.5M
Current Assets	$8.5M-63.6%	$23.4M+28.7%	$18.1M-35.2%	$28.0M-10.3%	$31.2M+30.8%	$23.9M-32.1%	$35.1M-34.7%	$53.8M-59.8%	$133.8M+130.4%	$58.1M+7883.2%	$728K
Cash & Equivalents	$2.6M+28.7%	$2.0M+154.0%	$800K-92.9%	$11.3M+84.8%	$6.1M+101.0%	$3.0M+204.1%	$1.0M-48.2%	$1.9M-85.2%	$13.0M+307.0%	$3.2M-59.0%	$7.8M
Short-Term Investments	$4.9M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	$3.6M-16.0%	$4.2M-37.4%	$6.8M+152.7%	$2.7M-41.1%	$4.5M-33.1%	$6.8M-59.6%	$16.8M+32.6%	$12.7M	N/A
Accounts Receivable	$156K+34.5%	$116K-46.8%	$218K-93.7%	$3.5M+53.9%	$2.3M+139.6%	$944K-44.4%	$1.7M-30.8%	$2.5M-96.1%	$63.2M+123.5%	$28.3M	N/A
Long-Term Investments	$0	$0	$0-100.0%	$338K+42.0%	$238K	$0	$0	$0	$0	$0	$0
Goodwill	N/A	$12.2M0.0%	$12.2M	N/A	$12.2M	N/A	N/A	$736K0.0%	$736K+6.2%	$693K-6.5%	$741K
Total Liabilities	$1.6M-94.5%	$29.0M-19.1%	$35.9M-13.2%	$41.3M-41.5%	$70.5M-23.0%	$91.6M-13.2%	$105.5M+2.6%	$102.9M-11.3%	$116.0M-13.0%	$133.4M+15.1%	$115.9M
Current Liabilities	$1.6M-94.1%	$26.9M-18.5%	$33.0M-13.0%	$37.9M-41.1%	$64.4M-25.8%	$86.8M-12.8%	$99.6M+19.8%	$83.1M-22.3%	$107.0M+112.0%	$50.5M	N/A
Non-Current Liabilities	$30K-98.6%	$2.1M-26.5%	$2.8M-15.2%	$3.4M-45.4%	$6.1M+28.5%	$4.8M-19.4%	$5.9M-69.9%	$19.7M+119.6%	$9.0M-36.0%	$14.0M	N/A
Long-Term Debt	N/A	N/A	$2.7M+58.5%	$1.7M+155.8%	$661K-47.1%	$1.3M	N/A	N/A	$18.1M+302.6%	$4.5M	N/A
Total Equity	$6.7M+297.7%	-$3.4M+75.0%	-$13.6M-26.2%	-$10.8M+53.6%	-$23.2M+62.6%	-$62.1M-40.2%	-$44.3M-99.8%	-$22.2M-147.2%	$47.0M+184.9%	-$55.4M+0.1%	-$55.4M
Retained Earnings	-$309.5M+1.7%	-$314.8M+5.0%	-$331.5M-8.7%	-$305.1M-12.6%	-$271.0M-26.0%	-$215.2M-19.8%	-$179.7M-22.9%	-$146.2M-96.9%	-$74.2M-35.7%	-$54.7M-83794.6%	-$65K

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K
Total Assets	$8.6M-66.3%	$23.9M	$25.4M+18.6%	$21.4M-28.9%	$26.4M-58.6%	$30.1M-43.4%	$63.6M+50.8%	$53.3M+81.4%
Current Assets	$8.5M-63.6%	$23.9M	$23.4M+28.7%	$18.1M-35.2%	$24.7M-38.9%	$28.0M-10.3%	$40.4M+8.0%	$31.2M+30.8%
Cash & Equivalents	$2.6M+28.7%	$9.6M	$2.0M+154.0%	$800K-92.9%	$8.3M-55.1%	$11.3M+84.8%	$18.4M+109.8%	$6.1M+101.0%
Short-Term Investments	$4.9M	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	$3.6M-16.0%	$5.5M-16.2%	$4.2M-37.4%	$6.6M-48.5%	$6.8M+152.7%
Accounts Receivable	$156K+34.5%	$837K	$116K-46.8%	$218K-93.7%	$1.0M-70.0%	$3.5M+53.9%	$3.3M+2.5%	$2.3M+139.6%
Long-Term Investments	$0	$0	$0	$0-100.0%	$0	$338K+42.0%	$0	$238K
Goodwill	N/A	N/A	$12.2M0.0%	$12.2M	N/A	N/A	$12.2M	$12.2M
Total Liabilities	$1.6M-94.5%	$19.3M	$29.0M-19.1%	$35.9M-13.2%	$37.0M-44.0%	$41.3M-41.5%	$66.1M+91.1%	$70.5M-23.0%
Current Liabilities	$1.6M-94.1%	$19.3M	$26.9M-18.5%	$33.0M-13.0%	$34.1M-43.3%	$37.9M-41.1%	$60.1M+93.9%	$64.4M-25.8%
Non-Current Liabilities	$30K-98.6%	$0	$2.1M-26.5%	$2.8M-15.2%	$2.9M-51.5%	$3.4M-45.4%	$5.9M+66.2%	$6.1M+28.5%
Long-Term Debt	N/A	N/A	N/A	$2.7M+58.5%	N/A	$1.7M+155.8%	N/A	$661K-47.1%
Total Equity	$6.7M+297.7%	$4.5M	-$3.4M+75.0%	-$13.6M-26.2%	-$10.6M-26.2%	-$10.8M+53.6%	-$8.4M-208.9%	-$23.2M+62.6%
Retained Earnings	-$309.5M+1.7%	-$309.0M	-$314.8M+5.0%	-$331.5M-8.7%	-$333.9M-20.4%	-$305.1M-12.6%	-$277.4M-33.5%	-$271.0M-26.0%

BRQSF Cash Flow Statement

BRQSF quarterly cash flow statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	-$27.9M-907.5%	-$2.8M+59.2%	-$6.8M-22.9%	-$5.5M+80.8%	-$28.7M-256.6%	-$8.1M-9.3%	-$7.4M-385.7%	$2.6M+120.4%	-$12.6M-40.4%	-$9.0M-650.7%	$1.6M
Depreciation & Amortization	$19K-95.3%	$403K-5.0%	$424K+12.8%	$376K+205.7%	$123K-17.4%	$149K+60.2%	$93K-76.5%	$395K-91.6%	$4.7M+48.2%	$3.2M+27.3%	$2.5M
Stock-Based Compensation	$2.4M+60800.0%	$4K-99.9%	$6.8M+145.0%	$2.8M-64.9%	$7.9M+164.4%	$3.0M+506.5%	$495K-49.3%	$976K-93.3%	$14.7M	N/A	N/A
Capital Expenditures	$37K-67.5%	$114K-54.4%	$250K-65.2%	$718K-8.1%	$781K+984.7%	$72K-38.5%	$117K-24.5%	$155K-81.6%	$842K+70.4%	$494K-38.1%	$798K
Free Cash Flow	-$27.9M-869.0%	-$2.9M+59.0%	-$7.0M-12.8%	-$6.2M+78.9%	-$29.5M-263.0%	-$8.1M-8.6%	-$7.5M-408.7%	$2.4M+118.0%	-$13.5M-42.0%	-$9.5M-1235.4%	$836K
Investing Cash Flow	$25.1M+154.1%	$9.9M+297.5%	-$5.0M-48.6%	-$3.4M-237.8%	-$998K-125.2%	$4.0M+638.6%	-$735K+82.8%	-$4.3M+47.5%	-$8.1M-54.2%	-$5.3M+28.5%	-$7.4M
Financing Cash Flow	-$411K+89.9%	-$4.0M-319.9%	$1.8M-87.6%	$14.9M-56.5%	$34.3M+2629.1%	-$1.4M-111.7%	$11.6M+200.5%	-$11.5M-136.2%	$31.9M+212.2%	$10.2M+7459.3%	$135K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$10.1M	N/A	N/A	N/A

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

BRQSF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRQSF quarterly financial ratios

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	3.7%-17.2pp	20.9%+2.1pp	18.8%+5.4pp	13.4%+4.6pp	8.8%+2.8pp	6.0%+5.4pp	0.6%-92.6pp	93.2%+77.9pp	15.3%-8.7pp	24.0%+1.3pp	22.7%
Operating Margin	-127.9%	-11.3%+43.8pp	-55.2%-46.8pp	-8.4%+80.1pp	-88.5%	-151.8%	-29.5%+22.5pp	-51.9%-45.0pp	-6.9%-17.1pp	10.2%+9.2pp	0.9%
Net Margin	39.4%-20.8pp	60.3%	-128.7%	-82.6%	-189.0%	-130.0%	-36.1%+19.8pp	-55.9%-45.6pp	-10.3%-14.1pp	3.8%+1.0pp	2.8%
Return on Equity	79.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-26.7%	N/A	N/A
Return on Assets	62.7%-3.0pp	65.7%+189.2pp	-123.5%-10.6pp	-112.9%-8.0pp	-104.9%+13.6pp	-118.5%-55.6pp	-62.9%+26.4pp	-89.3%-81.6pp	-7.7%-11.8pp	4.1%+0.6pp	3.5%
Current Ratio	5.39+4.5x	0.87+0.3x	0.55-0.2x	0.74+0.3x	0.48+0.2x	0.27-0.1x	0.35-0.3x	0.65-0.6x	1.25+0.1x	1.15	N/A
Debt-to-Equity	0.24	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.38	N/A	N/A
Asset Turnover	1.59+0.5x	1.09+0.1x	0.96-0.4x	1.37+0.8x	0.56-0.4x	0.91-0.8x	1.74+0.1x	1.60+0.8x	0.75-0.3x	1.10-0.1x	1.24
FCF Margin	-205.4%	-10.4%+23.8pp	-34.2%-19.1pp	-15.2%+84.7pp	-99.9%-69.5pp	-30.4%-22.8pp	-7.6%-9.5pp	1.9%+12.9pp	-11.0%+0.1pp	-11.1%-12.2pp	1.1%

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q	Q4'2110-K
Current Ratio	5.39+4.5x	1.24	0.87+0.3x	0.55-0.2x	0.72+0.1x	0.74+0.3x	0.67-0.5x	0.48+0.2x
Debt-to-Equity	0.24	4.32	N/A	N/A	N/A	N/A	N/A	N/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Borqs Technologi BRQSF	FY2025	$13.6M	$5.4M	39.4%	$4.9M	—
Apptech APCX	FY2025	$1.4M	-$7.9M	N/A	$8.7M	—

Where Borqs Technologi Ranks

Frequently Asked Questions

What is Borqs Technologi's annual revenue?

Borqs Technologi (BRQSF) reported $13.6M in total revenue for fiscal year 2025. This represents a -50.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Borqs Technologi's revenue growing?

Borqs Technologi (BRQSF) revenue declined by 50.9% year-over-year, from $27.7M to $13.6M in fiscal year 2025.

Is Borqs Technologi profitable?

Yes, Borqs Technologi (BRQSF) reported a net income of $5.4M in fiscal year 2025, with a net profit margin of 39.4%.

What is Borqs Technologi's EBITDA?

Borqs Technologi (BRQSF) had EBITDA of -$17.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Borqs Technologi's gross margin?

Borqs Technologi (BRQSF) had a gross margin of 3.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Borqs Technologi's net profit margin?

Borqs Technologi (BRQSF) had a net profit margin of 39.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Borqs Technologi's return on equity (ROE)?

Borqs Technologi (BRQSF) has a return on equity of 79.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Borqs Technologi's free cash flow?

Borqs Technologi (BRQSF) recorded an outflow of $27.9M in free cash flow during fiscal year 2025. This represents a -869.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Borqs Technologi's operating cash flow?

Borqs Technologi (BRQSF) recorded an outflow of $27.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Borqs Technologi's total assets?

Borqs Technologi (BRQSF) had $8.6M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Borqs Technologi's capital expenditures?

Borqs Technologi (BRQSF) invested $37K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Borqs Technologi spend on research and development?

Borqs Technologi (BRQSF) invested $3.5M in research and development during fiscal year 2025.

How many shares does Borqs Technologi have outstanding?

Borqs Technologi (BRQSF) had 45M shares outstanding as of fiscal year 2025.

What is Borqs Technologi's current ratio?

Borqs Technologi (BRQSF) had a current ratio of 5.39 as of fiscal year 2025, which is generally considered healthy.

What is Borqs Technologi's debt-to-equity ratio?

Borqs Technologi (BRQSF) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Borqs Technologi's return on assets (ROA)?

Borqs Technologi (BRQSF) had a return on assets of 62.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Borqs Technologi's P/E ratio?

Borqs Technologi (BRQSF) trades at 0.9x earnings, its market capitalization divided by net income of $5.4M net income, FY2025. The market capitalization is $4.9M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Borqs Technologi's price-to-sales ratio?

Borqs Technologi (BRQSF) trades at 0.4x sales, its market capitalization divided by revenue of $13.6M revenue, FY2025. The market capitalization is $4.9M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Borqs Technologi's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Borqs Technologi (BRQSF) held $7.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $27.9M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Borqs Technologi's Altman Z-Score?

Borqs Technologi (BRQSF) has an Altman Z-Score of -52.95, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Borqs Technologi's Piotroski F-Score?

Borqs Technologi (BRQSF) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Borqs Technologi's earnings high quality?

For every $1 of reported earnings, Borqs Technologi (BRQSF) used $5.20 of operating cash (-$27.9M OCF vs $5.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.